Trials / Completed
CompletedNCT01060033
MRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer
A Study of Novel Magnetic Resonance Imaging Sequences for Target Delineation and Prognostication in Cervical Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To detect differences in MR spectroscopy, diffusion weighted MR, diffusion tensor imaging (DTI) or dynamic contrast enhancement (DCE) MR imaging between primary cervical tumors and normal cervical tissue.
Detailed description
At our institution, all patients receiving external beam and/or brachytherapy as part of the treatment of primary cervical cancer receive CT, PET, and MRI simulation scans as standard of care. Brachytherapy patients also receive weekly T1/T2 weighted MR simulation scans as part of their treatment planning. We propose the use of additional MR sequences to the standard T1/T2 weighted MR simulation scans. The data obtained from these additional sequences will be used for improving tumor delineation and obtaining prognostic information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MR Spectroscopy | |
| DEVICE | Fat-Saturation and Diffusion-Weighted Imaging | |
| DEVICE | Dynamic Contrast Enhancement MRI (MR-DCE) | |
| DEVICE | Diffusion Tensor Imaging (DTI) |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2010-02-01
- Last updated
- 2017-04-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01060033. Inclusion in this directory is not an endorsement.